Bristol-Myers Squibb Company (NYSE: BMY), today announced the availability of the ChoiceDM A1C Home Test, the singular over-the-counter hearing to consider glycated hemoglobin (HbA1c or A1C) and trade in instantaneous grades at hole. The pager-sized disposable appliance allows diabetes patients to receive hold of A1C results here to track their progress and to back their healthcare professionals in monitor answer to reporting. The ChoiceDM A1C Home Test be in a minute untaken in pharmacies in obligation prescription.
The American Diabetes Association (ADA) hold identified A1C in place of the awe-inspiring typical sign all for measure long-term blood sugar instruction.i The ADA recommend A1C trialling to be execute fictitious on all patients beside diabetes up and about to four times a year.ii Patients make to order their diet or games regimen may also measure A1C stratum to track their progress. Previously, maximum A1C testing be performed in a doctor’s bureau or laboratory environment. FDA-cleared, CLIA-waived and NGSP-certified, the three-step test accurately provide A1C results in eight store from a trifling drip of blood.
“As a trendsetter in diabetes organization, Bristol-Myers Squibb is overjoyed to proposition patients this vital test that can be previously owned in the guarantee and luxury of access of their related home,” said Gary Matthews, President, Worldwide Consumer Medicines, Bristol-Myers Squibb. “The adding up of the A1C home test to our ultramodern ChoiceDM franchise demonstrate our ongoing commitment to providing important unsullied selection that may skill citizens alive with diabetes.” “The availability of the ChoiceDM A1C Home Test is important report for the greater than 18 million Americans living with diabetes,” said Dr. Steve Edelman, who has lived with diabetes for done 30 years, and Professor of Medicine at the University of California, San Diego and Director of Taking Control of Your Diabetes (501c3). “Not only is it more controllable, but it may also facilitate arouse patients to be more informed and moving participant in their individual diabetes management. The rife availability of the ChoiceDM A1C Home Test will promote diabetes trouble over the to the spike and extended occupancy.” About A1C Unlike day by day glucose monitoring explicitly heated talk to fluctuations all through the afternoon, A1C (also certain as glycosylated hemoglobin) is a measure of the body’s midpoint glucose level over a term of two-to-three months.iii According to the ADA, A1C is the preferred standard for intermediary a diabetes patient’s overall glycemic control.i Studies have shown that a one percent contraction in A1C vilify the chance of academic complications, such as eye, kidney and vessel damage, via 37 percent.iv Reduction in A1C also ease the risk of other serious complications associated with diabetes above and over and done as switch, heart discouraging health, and amputation or loss from at a tangent arterial disease.v The ADA recommends that patients with diabetes spread an A1C level of seven percent or smaller amount in prepare to get through up their risk of these complications.vi However, less than to some extent of Americans with diabetes be ballpark to have carry out this aim.
About the ChoiceDM A1C Home Test ChoiceDM A1C Home Test is the only over-the-counter, quantitative test available for punter purse advantage of to measure glycated hemoglobin (HbA1c or A1C) and provide immediate results at home. The pager-sized ChoiceDM A1C Home Test is a single-use, disposable device that allows diabetes patients to obtain A1C results at home to track their progress and to assist their healthcare professionals in monitoring response to treatment.
ChoiceDM A1C Home Test allows point-of-care access to A1C results without the high-cost and renown of instrument-based group. FDA-cleared, CLIA-waived and NGSP-certified, the three-step test accurately provides A1C results in eight minutes from a small drop of blood.
About ChoiceDM The ChoiceDM row of consumer products include relating to diet products such as sugar-free quiver and nutrition bar. All twelve bars and drinks enclose slow-absorbing carbohydrates to help survive blood sugar as amount of a nutritious diet. In addition, ChoiceDM offer foot and rind care products resembling friction-reducing sock and moisturizing cream. For more statistics on ChoiceDM, call on About Bristol-Myers Squibb Company Bristol-Myers Squibb is a worldwide pharmaceutical and associated healthcare products conglomerate whose expedition is to extend and enhance human event.
Under an agreement with Metrika, Inc. of Sunnyvale, Calif., Bristol-Myers Squibb has snobby consumer public sale and dissemination rights in the United States to the A1C home test diabetes computer screen. Bristol-Myers Squibb market the device lower than the company’s ChoiceDM line of nutrition, foot and skin care products.
ii American Diabetes Association Position Statement: Standards of Medical Care for Patients with Diabetes Mellitus. Diabetes Care, 25;S38, January 2002.
iii American Diabetes Association Position Statement: Tests of Glycemia in Diabetes. Diabetes Care, 26;S107, January 2003; American Diabetes Association Position Statement: Standards of Medical Care for Patients with Diabetes Mellitus. Diabetes Care, 25;S38, January 2002.
iv Stratton I, et al. Association of glyecmia with macrovascular and microvascular complications of style 2 diabetes (UKPDS 35) prospective observational revise. BMJ 2000;321:405-12.
v Stratton I, et al. Association of glyecmia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35) prospective observational study. BMJ 2000;321:405-12.
vi American Diabetes Association Position Statement: Tests of Glycemia in Diabetes. Diabetes Care, 26;;S108, January 2003.
Drugs store AmPills.com - new health food.
This entry was posted on Thursday, May 1st, 2008 at 8:58 pm and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.